Cardiovascular Risk Stratification in Covid-19
NCT04555187 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1355
Last updated 2023-11-07
Summary
This retrospective double-cohort study seeks to:
1. Describe the cardiovascular manifestations and electrophysiological (EP) substrate in COVID-19 infection and their association with clinical outcomes; and
2. Develop a method of cardiovascular risk stratification in COVID-19
Conditions
- Covid19
- Cardiovascular Risk Factor
Sponsors & Collaborators
-
Oregon Health and Science University
lead OTHER
Principal Investigators
-
Larisa G Tereshchenko, MD, PhD · Oregon Health and Science University
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-08
- Primary Completion
- 2021-12-01
- Completion
- 2021-12-01
Countries
- United States
Study Locations
More Related Trials
-
SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET
NCT02325531 ·Status: COMPLETED ·Phase: NA
-
Effect of COVID-19 on Endothelial Function
NCT05500560 ·Status: COMPLETED
-
Self-Scored Cardiovascular Disease Risk Appraisal
NCT00005529 ·Status: COMPLETED
-
Cardiovascular Health Study (CHS)
NCT00005133 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic Epidemiology of CVD Risk Factors
NCT00053521 ·Status: COMPLETED
-
Molecular Investigation of Genetic Factors in CArDiovascular Diseases Using an BIOresource of Healthy Volunteers
NCT03038750 ·Status: TERMINATED
-
Inflammation, Infection, and Future Cardiovascular Risk
NCT00005496 ·Status: COMPLETED
-
Inflammation Markers Over Time in Cardiovascular Disease
NCT00005692 ·Status: COMPLETED
-
Prospective Study of Diet and Cardiovascular Disease
NCT00005519 ·Status: COMPLETED
-
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
NCT06280820 ·Status: ENROLLING_BY_INVITATION
-
Mechanisms Underlying Cardiovascular Consequences Associated With COVID-19 and Long COVID
NCT06427512 ·Status: WITHDRAWN
-
Epidemiology of Cardiovascular Diseases in The Elderly
NCT00005186 ·Status: COMPLETED
-
MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction
NCT00859300 ·Status: COMPLETED
-
Covid-19, Acute Myocardial Infarctions and Strokes in France
NCT04542083 ·Status: TERMINATED
-
Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia
NCT00005313 ·Status: COMPLETED
-
Genetic Markers of CHD Risk in Men and Women
NCT00090454 ·Status: COMPLETED
-
Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19
NCT04560608 ·Status: UNKNOWN
-
Hispanic and White Women's Cardiovascular Health
NCT00005477 ·Status: COMPLETED
-
Utility of the SomaLogic Cardiovascular Disease (CVD) Secondary Risk Panel for Cardiovascular Risk
NCT03599531 ·Status: COMPLETED
-
Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events
NCT04519398 ·Status: UNKNOWN
-
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
NCT06122961 ·Status: COMPLETED
-
Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study
NCT04357314 ·Status: COMPLETED
-
Correlation Between Cardiac Markers and Severity of COVID-19
NCT05040750 ·Status: COMPLETED
-
Common Variants in Candidate Genes and Premature MI Risk
NCT00005488 ·Status: COMPLETED
-
Predicting Risk of Atrial Fibrillation and Association With Other Diseases
NCT05837364 ·Status: COMPLETED